A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal nocturnal haemoglobinuria

BMC Blood Disorders

Volumn 4, Issue , 2004, Pages

  Keith, W Nicol ^a   Vulliamy, Tom ^b   Zhao, Jiangqin ^a   Ar, Cem ^c   Erzik, Can ^d   Bilsland, Alan ^a   Ulku, Birsen ^c   Marrone, Anna ^b   Mason, Philip J ^b,e   Bessler, Monica ^e   Serakinci, Nedime ^f   Dokal, Inderjeet ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c ISTANBUL UNIVERSITY   (Turkey)

^d MARMARA UNIVERSITY   (Turkey)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PREDNISOLONE; RNA; STEROID; TELOMERASE; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BINDING SITE; BONE MARROW BIOPSY; CASE REPORT; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DOWN REGULATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; GEL MOBILITY SHIFT ASSAY; GENE AMPLIFICATION; GENE FUNCTION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; MALE; MYOPATHY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHYSICAL EXAMINATION; PROMOTER REGION; PROTEIN BINDING; THROMBOCYTE TRANSFUSION; UPREGULATION;

EID: 13144281829     PISSN: 14712326     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2326-4-3     Document Type: Article

References (21)

1. Dokal I: Dyskeratosis congenita in all its forms. Br J Haematol 2000, 110:768-779.
2. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I: X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998, 19:32-38.
3. Filipowicz W, Pogacic V: Biogenesis of small nucleolar ribonucleoproteins. Curr Opinion Cell Biol 2002, 14: 19-327.
4. Mitchell JR, Wood E, Collins K: A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999, 402:551-555.
5. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I: The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001, 413: 32-435.
6. Yamaguchi H, Baerlocher GM, Lansdorp PM, Chanock SJ, Nunez O, Sloand E, Young NS: Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 2003, 102:916-918.
7. Vulliamy T, Marrone A, Dokal I, Mason PJ: Association between aplastic anaemia and mutations in telomerase RNA. Lancet 2002, 359:2168-2170.
8. Kinoshita T, Inoue N: Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Int J Hematol 2002, 75:117-122.
9. Bessler M, Schaefer A, Keller P: Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology. Transfus Med Rev 2001, 15:255-267.
10. Zhao JQ, Hoare SF, McFarlane R, Muir S, Parkinson EK, Black DM, Keith WN: Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 1998, 16: 345-1350.
11. Zhao JQ, Glasspool RM, Hoare SF, Bilsland A, Szatmari I, Keith WN: Activation of telomerase rna gene promoter activity by NFY, Sp1, and the retinoblastoma protein and repression by Sp3. Neoplasia 2000, 2:531-539.
12. Yamada K, Tanaka T, Miyamoto K, Noguchi T: Sp family members and nuclear factor-Y cooperatively stimulate transcription from the rat pyruvate kinase M gene distal promoter region via their direct interactions. J Biol Chem 2000, 275:18129-18137.
13. Zhao J, Bilsland A, Hoare SF, Keith WN: Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. FEBS Lett 2003, 536:111-119.
14. Hathcock KS, Hemann MT, Opperman KK, Strong MA, Greider CW, Hodes RJ: Haploinsufficiency of mTR results in defects in telomere elongation. Proc Natl Acad Sci U S A 2002, 99:3591-3596.
15. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP: Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003, 299: 59-262.
16. Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I: Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet 2001, 108:299-303.
17. Salowsky R, Heiss NS, Benner A, Wittig R, Poustka A: Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1 binding site is associated with decreased promoter activity. Gene 2002, 293:9-19.
18. Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM: Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood 2001, 97:895-900.
19. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC: Progressive telomere shortening in aplastic anemia. Blood 1998, 91:3582-3592.
20. Lee JJ, Kook H, Chung IJ, Na JA, Park MR, Hwang TJ, Kwak JY, Sohn SK, Kim HJ: Telomere length changes in patients with aplastic anaemia. Br J Haematol 2001, 112:1025-1030.
21. Karadimitris A, Araten DJ, Luzzatto L, Notaro R: Severe telomere shortening in patients with paroxysmal nocturnal hemoglobinuria affects both GPI- and GPI+ hematopoiesis. Blood 2003, 102: 14-516.